These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22542706)

  • 21. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
    She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
    Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
    Mamon HJ; Yeap BY; Jänne PA; Reblando J; Shrager S; Jaklitsch MT; Mentzer S; Lukanich JM; Sugarbaker DJ; Baldini EH; Berman S; Skarin A; Bueno R
    J Clin Oncol; 2005 Mar; 23(7):1530-7. PubMed ID: 15735128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assessment of surgery for stage IV non-small cell lung cancer].
    Yamada T; Tanahashi M; Moriyama T; Hikosaka Y; Yoshitomi H
    Kyobu Geka; 2006 Jan; 59(1):4-10. PubMed ID: 16440677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
    Sperduto PW; Yang TJ; Beal K; Pan H; Brown PD; Bangdiwala A; Shanley R; Yeh N; Gaspar LE; Braunstein S; Sneed P; Boyle J; Kirkpatrick JP; Mak KS; Shih HA; Engelman A; Roberge D; Arvold ND; Alexander B; Awad MM; Contessa J; Chiang V; Hardie J; Ma D; Lou E; Sperduto W; Mehta MP
    JAMA Oncol; 2017 Jun; 3(6):827-831. PubMed ID: 27892978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective.
    Paralkar VR; Li T; Langer CJ
    Clin Lung Cancer; 2008 Mar; 9(2):116-21. PubMed ID: 18501099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
    Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
    Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
    Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?
    Nieder C; Pawinski A; Molls M
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):65-9. PubMed ID: 19762219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival.
    Frazier JL; Batra S; Kapor S; Vellimana A; Gandhi R; Carson KA; Shokek O; Lim M; Kleinberg L; Rigamonti D
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1486-92. PubMed ID: 19619958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma.
    Bajard A; Westeel V; Dubiez A; Jacoulet P; Pernet D; Dalphin JC; Depierre A
    Lung Cancer; 2004 Sep; 45(3):317-23. PubMed ID: 15301872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
    Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.
    Ceresoli GL; Reni M; Chiesa G; Carretta A; Schipani S; Passoni P; Bolognesi A; Zannini P; Villa E
    Cancer; 2002 Aug; 95(3):605-12. PubMed ID: 12209754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial.
    Bennouna J; Senellart H; Hiret S; Vaissiere N; Douillard JY
    Lung Cancer; 2011 Oct; 74(1):30-4. PubMed ID: 21371774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the graded prognostic assessment index for surgically treated patients with brain metastases.
    Nieder C; Geinitz H; Molls M
    Anticancer Res; 2008; 28(5B):3015-7. PubMed ID: 19031949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.
    Werner-Wasik M; Scott C; Cox JD; Sause WT; Byhardt RW; Asbell S; Russell A; Komaki R; Lee JS
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1475-82. PubMed ID: 11121651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison between cyberknife and neurosurgery in solitary brain metastases from non-small cell lung cancer.
    Tian LJ; Zhuang HQ; Yuan ZY
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2009-14. PubMed ID: 23850045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors.
    Sperduto PW; De B; Li J; Carpenter D; Kirkpatrick J; Milligan M; Shih HA; Kutuk T; Kotecha R; Higaki H; Otsuka M; Aoyama H; Bourgoin M; Roberge D; Dajani S; Sachdev S; Gainey J; Buatti JM; Breen W; Brown PD; Ni L; Braunstein S; Gallitto M; Wang TJC; Shanley R; Lou E; Shiao J; Gaspar LE; Tanabe S; Nakano T; An Y; Chiang V; Zeng L; Soliman H; Elhalawani H; Cagney D; Thomas E; Boggs DH; Ahluwalia MS; Mehta MP
    Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):60-74. PubMed ID: 35331827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.
    Enders F; Geisenberger C; Jungk C; Bermejo JL; Warta R; von Deimling A; Herold-Mende C; Unterberg A
    Clin Neurol Neurosurg; 2016 Mar; 142():72-80. PubMed ID: 26816105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.